About TB-500 Dr

The TB-500 Dr name

TB-500 Dr is where I examine the published research; it offers no medical advice. I’m no doctor. “Dr” names this site. There are no prescriptions, sales, shipments or bookings through this site, and it offers no diagnosis or treatment.

I expected more clinical certainty from this name than the papers delivered. Then the fragment itself led me to chemical identification and racehorse doping control. The strongest human experiments nearby used full-length thymosin beta-4. That mismatch is the reason for these pages.

There is interesting biology here. There is also a habit of assigning the parent protein's results to the shorter peptide, then assigning an animal result to a human hope. I object to those substitutions because they make an unsettled question look finished.

The awkward results are part of the interest

I admire experiments that separate an appealing observation from the outcome someone actually needs. The mdx mouse study increased regenerating fibers without significant gains in muscle strength. The rat stroke study found no significant benefit at the highest tested amount. Neither fits a smooth repair story, and neither deserves to disappear from it.

The eye studies also deserve their own space. A topical thymosin beta-4 formulation in a human trial is a real intervention with its own setting and endpoints. Its findings stay specific to that intervention, setting and endpoints; a different fragment and injury require their own evidence. The parent-protein page follows that record.

I enjoy a plausible explanation most when a stubborn measurement puts it to work. A fragment-specific controlled human study, with useful functional outcomes and adequate safety follow-up, would have a much stronger claim on my confidence than another catalogue of mechanisms. Until then, the medical reputation remains ahead of the evidence.

Corrections to a study description or a dated regulatory statement belong on the contact page. A source that changes a conclusion is welcome; reassurance without a source is less useful.